Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
25:46
Antibody Drug Conjugates Present and Future Applications in Breast Cancer
28:55
Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA
32:00
Clinical Cases in HR-Positive, HER2-Negative Early Breast Cancer: Applying the Latest Evidence
21:08
Day 2 | K RAS Targeting – The Cusp of a Game Changer Target - Axel Grothey, MD – West Cancer Center
1:18:51
Medical advances in the treatment of metastatic breast cancer
1:35:38
UCSF Bay Area Breast Cancer Forum: "Updates from ASCO 2024”
56:32
Antibody Drug Conjugates for Cancer
20:17